Godavari Biorefineries is locked its upper circuit limit at Rs. 301.50, up by 14.35 points or 5.00% from its previous closing of Rs. 287.15 on the BSE.

The scrip opened at Rs. 301.50 and has touched a high and low of Rs. 301.50 and Rs. 301.50 respectively. So far 431 shares were traded on the counter.

The BSE group 'T' stock of face value Rs. 10 has touched a 52 week high of Rs. 408.25 on 09-Dec-2024 and a 52 week low of Rs. 145.20 on 28-Mar-2025.

Last one week high and low of the scrip stood at Rs. 301.50 and Rs. 270.55 respectively. The current market cap of the company is Rs. 1542.96 crore.

The promoters holding in the company stood at 63.31%, while Institutions and Non-Institutions held 15.14% and 21.55% respectively.

Godavari Biorefineries has secured Chinese Patent for cancer treatment compound. China National Intellectual Property Administration (CNIPA) has granted patent entitled, ‘5-Hydroxy-1,4-Naphthalenedione for use in the Treatment of Cancer’.

This patent covers a novel class of compounds that have exhibited strong inhibitory effects on cancer and cancer stem cells in vitro studies. These compounds have demonstrated significant efficacy against multiple cancer cell types, including breast and prostate cancer. 

Godavari Biorefineries is one of the manufacturers of ethanol based chemicals in India. Its diversified product portfolio comprises of bio-based chemicals, sugar, different grades of ethanol and power.